Operators may place on the market the following derived products:
(a)
cosmetic products as defined in Article 1(1) of Directive 76/768/EEC;
(b)
active implantable medical devices as defined in Article 1(2)(c) of Directive 90/385/EEC;
(c)
medical devices as defined in Article 1(2)(a) of Directive 93/42/EEC;
(d)
in vitro diagnostic medical devices as defined in Article 1(2)(b) of Directive 98/79/EC;
(e)
veterinary medicinal products as defined in Article 1(2) of Directive 2001/82/EC;
(f)
medicinal products as defined in Article 1(2) of Directive 2001/83/EC.
Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04
CitationArticle 33 of Regulation (EC) No 1069/2009 (LawPlayer, data as of 2026-07-04)
